News

/News

Understanding Nonclinical Auditory Safety Evaluations

Auditory safety evaluations are recommended for any drug administered into the middle ear or that may come in contact with the middle or inner ear tissues. In addition to otically administered compounds, some classes of systemically administered drugs should also be considered for evaluation. […]

By | 2014-03-17T14:56:41+00:00 November 27th, 2012|News|Comments Off on Understanding Nonclinical Auditory Safety Evaluations

MPI Research Presents at Drug Development Boot Camp!

Dear Colleague,

MPI Research scientists, Scott Boley, PhD, DABT, Senior Director of General Toxicology and Infusion Toxicology, and Thomas Vihtelic, DVM, PhD, Director of Experimental Therapeutics, with a team of esteemed industry and regulatory drug development experts, will present at the upcoming seminar, Drug Development Boot Camp, November 14-15, 2012 at Harvard University. This […]

By | 2017-07-04T10:28:55+00:00 November 8th, 2012|News|Comments Off on MPI Research Presents at Drug Development Boot Camp!

QWBA Lab Achieves Full GLP Validation

MPI Research, the largest single-site preclinical Contract Research Organization (CRO) worldwide, is pleased to announce that its Quantitative Whole-Body Autoradiography (QWBA) laboratory has achieved full GLP validation. Ms. Andrea Knapp, MPI Research scientist, manages the QWBA laboratory. Mr. Brian Knapp, associate Study Director, provides appropriate QWBA study design and interpretation. Together, they have nearly 25 […]

By | 2014-03-17T14:57:00+00:00 October 29th, 2012|News|Comments Off on QWBA Lab Achieves Full GLP Validation

American Association of Pharmaceutical Scientists Annual Meeting and Exposition

MPI Research is pleased to support the American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS), taking place October 14 – 18, 2012, at McCormick Place, in Chicago, Illinois. We will be delivering multiple scientific presentations at this year’s meeting.

Karina Kwok, PhD, will moderate the “Hot Topics” session, Drug Development at a Small Company, […]

By | 2017-07-04T10:29:00+00:00 October 11th, 2012|News|Comments Off on American Association of Pharmaceutical Scientists Annual Meeting and Exposition

Integration of Molecular Imaging Solutions to Facilitate Preclinical Drug Development

How Can Molecular Imaging Improve My Drug Development Program?

The incorporation of molecular imaging solutions into drug development programs allows investigators to receive rapid results, assess their compound of interest and make critical go/no-go decisions earlier in the development process. At MPI Research, we routinely use cutting-edge technology in molecular imaging and radiochemistry to assist our […]

By | 2017-07-04T10:29:02+00:00 September 24th, 2012|News|Comments Off on Integration of Molecular Imaging Solutions to Facilitate Preclinical Drug Development

Directions in Discovery and Development

This issue of Directions in Discovery and Development covers topics in the Discovery arena, with a focus on ocular disease, metabolic disease, drug metabolism, and pharmacokinetics (DMPK). Our Experimental Therapeutics program provides Sponsors with a collaborative approach to evaluating efficacy, proof-of-concept, and translational sciences in many therapeutic areas and covers a wide range of indications. […]

By | 2017-07-04T10:29:07+00:00 September 21st, 2012|News|Comments Off on Directions in Discovery and Development

The Next World War – Defeating Diabetes

Here’s a shocking fact: 346 million people worldwide have diabetes. More than 90 percent of them – including an increasing number of children—have type 2 diabetes, putting them at greater risk for heart disease, stroke, blindness, neuropathy, kidney failure, and death.1 The rising obesity rate – […]

By | 2017-07-04T10:29:13+00:00 June 13th, 2012|News|Comments Off on The Next World War – Defeating Diabetes

Göttingen Minipigs in Preclinical Toxicology – a Webinar

The Other Nonrodent: Göttingen Minipigs in Preclinical Toxicology,” Tuesday, June 19, 2012, from 11 am to 12 pm EDT

Register today for “The Other Nonrodent: Göttingen Minipigs in Preclinical Toxicology,” an educational, complimentary webinar hosted by Dr. Scott E. Boley and Ms. Lisa Craig. […]

By | 2017-07-04T10:29:14+00:00 June 8th, 2012|News|Comments Off on Göttingen Minipigs in Preclinical Toxicology – a Webinar

Take a Peek at our High-Throughput AMD Model

Many baby boomers are entering their twilight years at risk of losing their sight because of age-related eye diseases.

Among the most debilitating is age-related macular degeneration (AMD), the leading cause of blindness among people over the age of 55 in developed nations. In the United States alone, 13 million people are at some stage of the disease.1 The “dry” […]

By | 2017-07-04T10:29:16+00:00 May 24th, 2012|News|Comments Off on Take a Peek at our High-Throughput AMD Model